Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

8 in Phase 3

Quick facts

Phase 3 pipeline

Docetaxel combined + Trastuzumab +Pertuzumab · Oncology
This combination uses a microtubule-stabilizing chemotherapy agent (docetaxel) together with two HER2-targeting monoclonal antibodies (trastuzumab and pertuzumab) to inhibit HER2-driven cancer cell growth through multiple mechanisms.
Gemcitabine hydrochloride for injection · Oncology
Gemcitabine is a nucleoside analog that inhibits ribonucleotide reductase and gets incorporated into DNA, causing chain termination and cell death.
Tislelizumab+Oxaliplatin+Capecitabine · Oncology
This combination uses a PD-1 inhibitor to enhance immune response against cancer cells while chemotherapy agents directly kill rapidly dividing cells.
TQB2102 for injection
TQB2102 for injection's mechanism is not publicly available.
TQB2102 Injection
TQB2102 Injection's mechanism is not publicly available.
TQB2868 injection
TQB2868 injection's mechanism is not publicly available.
TQB2930+ chemotherapy · Oncology
TQB2930 is a chemotherapy drug that targets cancer cells.
Trastuzumab+ chemotherapy · Oncology
Trastuzumab is a monoclonal antibody that blocks HER2 signaling on cancer cells, combined with chemotherapy to enhance tumor cell death.

Phase 2 pipeline

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

What is Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.'s pipeline?

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. has 8 drugs in Phase 3, 2 in Phase 2, 5 in Phase 1. Late-stage candidates include Docetaxel combined + Trastuzumab +Pertuzumab, Gemcitabine hydrochloride for injection, Tislelizumab+Oxaliplatin+Capecitabine, TQB2102 for injection.

Sector hub: All tracked pharma companies